BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15100315)

  • 21. Attenuation of experimental autoimmune demyelination in complement-deficient mice.
    Nataf S; Carroll SL; Wetsel RA; Szalai AJ; Barnum SR
    J Immunol; 2000 Nov; 165(10):5867-73. PubMed ID: 11067947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
    Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
    J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.
    Valentin-Torres A; Savarin C; Barnett J; Bergmann CC
    J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease.
    Sabelko-Downes KA; Russell JH; Cross AH
    J Neuroimmunol; 1999 Dec; 100(1-2):42-52. PubMed ID: 10695714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.
    Hisahara S; Araki T; Sugiyama F; Yagami Ki; Suzuki M; Abe K; Yamamura K; Miyazaki J; Momoi T; Saruta T; Bernard CC; Okano H; Miura M
    EMBO J; 2000 Feb; 19(3):341-8. PubMed ID: 10654933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis.
    Hövelmeyer N; Hao Z; Kranidioti K; Kassiotis G; Buch T; Frommer F; von Hoch L; Kramer D; Minichiello L; Kollias G; Lassmann H; Waisman A
    J Immunol; 2005 Nov; 175(9):5875-84. PubMed ID: 16237080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
    Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes.
    Chen L; Brosnan CF
    J Immunol; 2006 Mar; 176(5):3115-26. PubMed ID: 16493071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis.
    Djerbi M; Abdul-Majid KB; Abedi-Valugerdi M; Olsson T; Harris RA; Grandien A
    J Immunol; 2003 Feb; 170(4):2064-73. PubMed ID: 12574377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination.
    Hisahara S; Yuan J; Momoi T; Okano H; Miura M
    J Exp Med; 2001 Jan; 193(1):111-22. PubMed ID: 11136825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H; Cudrici C; Niculescu F
    Adv Exp Med Biol; 2006; 586():139-51. PubMed ID: 16893070
    [No Abstract]   [Full Text] [Related]  

  • 37. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sildenafil ameliorates EAE by decreasing apoptosis in the spinal cord of C57BL/6 mice.
    Duarte-Silva E; Araújo SMDR; Oliveira WH; Lós DB; França MER; Bonfanti AP; Peron G; Thomaz LL; Verinaud L; Nunes AKS; Peixoto CA
    J Neuroimmunol; 2018 Aug; 321():125-137. PubMed ID: 29957383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
    Calida DM; Constantinescu C; Purev E; Zhang GX; Ventura ES; Lavi E; Rostami A
    J Immunol; 2001 Jan; 166(2):723-6. PubMed ID: 11145641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.